Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Diagnostics » Molecular Diagnostics » Explosive Detection Device Manufacturer DetectaChem Pivots to SARS-CoV-2 Testing

Explosive Detection Device Manufacturer DetectaChem Pivots to SARS-CoV-2 Testing

Feb 04, 2021
|
Kelsy Ketchum
Premium

NEW YORK – A company with expertise in detecting the presence of explosives or drugs may not be the first place someone would go for a SARS-CoV-2 test.

But Stafford, Texas-based DetectaChem is working to change that perception with its COVID-19 tests based on the automated colorimetric technology it has used for 15 years to detect explosives and narcotics. "Our core business is detection, whether it be of explosives, drugs, or now biologics," COO Travis Kisner said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Letter Urges New Inquiry

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

Great Apes Get Shots, Too

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Woodcock on Vaccines, More

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

Science Paper Examines Molecular Contributors to Kidney Fibrosis

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.

Mar
18
Featured Webinar

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Featured Webinar

Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs

Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

What's Popular?

In COVID-19

  1. Cue Health Over-the-Counter COVID-19 Test Gets FDA Emergency Use Authorization

  2. At AGBT, Two Labs Share SARS-CoV-2 Genomic Surveillance Experience

    Premium

  3. Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

  4. Fulgent Genetics Q4 Revenues Skyrocket

  5. T2 Biosystems Q4 Revenues Jump 152 Percent on Strong Product Sales

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.